This inventor holds 2 USPTO granted patents. Top assignee: University of Pennsylvania. Active years: 2011-2015.
Location History:
- Philadelphia, PA (US) (2011)
- Haverford, PA (US) (2015)
Company Filing History:
Years Active: 2011-2015
Title: Thomas Cappola: Innovator in Cardiac Diagnostics
Introduction
Thomas Cappola is a distinguished inventor based in Haverford, PA (US). He has made significant contributions to the field of cardiac health through his innovative patents. With a total of 2 patents, his work focuses on improving the diagnosis and management of heart failure and transplant rejection.
Latest Patents
Cappola's latest patents include groundbreaking methods for diagnosing heart failure and other cardiac diseases. This invention relates to methods of diagnosing the severity of heart failure or cardiac dysfunction in a subject. It also encompasses monitoring the severity of heart failure and determining the prognosis for individuals who have experienced heart failure. Additionally, this invention identifies patients at risk for cardiac dysfunction when exposed to cardiotoxic chemotherapy agents. Another notable patent is related to predictors of transplant rejection determined by peripheral blood gene-expression profiling. This invention provides methods and kits for predicting transplant rejection or tolerance, as well as methods for predicting the probability of cardiac allograft rejection through profiling of peripheral blood gene expression.
Career Highlights
Cappola is affiliated with the University of Pennsylvania, where he continues to advance research in cardiac health. His work has garnered attention for its potential to improve patient outcomes in heart disease and transplant scenarios.
Collaborations
Cappola collaborates with esteemed colleagues such as Douglas B Sawyer and Bonnie Ky, contributing to a rich environment of innovation and research.
Conclusion
Thomas Cappola's contributions to cardiac diagnostics exemplify the impact of innovative thinking in medicine. His patents not only enhance the understanding of heart failure but also pave the way for improved patient care.